Phase I/II Study of IPG1094 in Advanced Solid Tumors Patients
Phase I/II Study of IPG1094 in Advanced Solid Tumors Patients
Recruiting · NCT06212076 · Registry updated 2025-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I/II Study of IPG1094 in Advanced Solid Tumors Patients | Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2025-09-24 | NCT06212076 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nanjing Immunophage Biotech Co., Ltd | 4 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai General Hospital | Shanghai | China | 59 |
| Shanghai GoBroad Cancer Hospital China Pharmaceutical University | Shanghai | China | 1 |